홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

로독사미드

Lodoxamide

HCID 44564
새 반응
인쇄

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
53882-12-5
표준 SMILES
N#Cc1cc(NC(=O)C(=O)O)c(Cl)c(NC(=O)C(=O)O)c1
InChIKey
RVGLGHVJXCETIO-UHFFFAOYSA-N
분자식
C11H6ClN3O6
평균 분자량
311.63 g/mol
단동위원소 질량
310.9945126

개요

Lodoxamide is an organonitrogen compound and an organooxygen compound. It is functionally related to an alpha-amino acid.

이름 및 식별자

우선 이름
Lodoxamide
IUPAC
2-[2-chloro-5-cyano-3-(oxaloamino)anilino]-2-oxoacetic acid
현지명
로독사미드
영어명
Lodoxamide
분자식
C11H6ClN3O6
분자량
311.63

이름 및 동의어

Lodoxamide53882-12-5LodoxamidaLodoxamidumDTXSID9057767SPU695OD73DTXCID0031556N,N'-(2-chloro-5-cyano-m-phenylene)dioxamateAcetic acid, 2,2'-((2-chloro-5-cyano-1,3-phenylene)diimino)bis(2-oxo-{[3-(carboxyformamido)-2-chloro-5-cyanophenyl]carbamoyl}formic acidAcetic acid, 2,2'-[(2-chloro-5-cyano-1,3-phenylene)diimino]bis[2-oxo-((3-(carboxyformamido)-2-chloro-5-cyanophenyl)carbamoyl)formic acid
이름 더 보기
로독사미드Unii-spu695od73LODOXAMIDE USP/EP/BPLodoxamide (U42585E)Lodoxamide lmpurity 16Lodoxamide lmpurity 01Lodoxamidum [inn-latin]Lodoxamida [inn-spanish]Lodoxamide, 10 mM in DMSO
2-((2-chloro-5-cyano-3-(oxaloamino)phenyl)amino)-2-oxoacetic acid2-[[2-chloro-5-cyano-3-(oxaloamino)phenyl]amino]-2-oxoacetic acidRefChem:58567S01GX052-[2-chloro-5-cyano-3-(oxaloamino)anilino]-2-oxoacetic acid2,2'-((2-Chloro-5-cyano-1,3-phenylene)bis(azanediyl))bis(2-oxoacetic acid)U-42585E (free acid)Lodoxamide (INN)

물성

구조 계산 물성보충 중

XLogP
0.5
극성 표면적
157 Ų
수소 결합 공여자 수
4
수소 결합 수용자 수
7
회전 가능 결합 수
4
무거운 원자 수
21
형식 전하
0
복잡도
489

실험 및 물리화학적 성질

DrugsPharmaceuticals -> Listed in ZINC15
Human DrugsBreast Feeding; Lactation; Milk, Human; Anti-Allergic Agents; Histamine Antagonists

물리화학적 성질

녹는점
212 ° · 212° (dec)
밀도
1.78 · 1.78±0.1 g/cm3(Predicted)
저장 조건
-20 °C · Store at -20°C
용해도
3 mg/ml; · DMF: 3 mg/ml; DMSO: 5 mg/ml; PBS (pH 7.2): 2 mg/mL
물리적 상태
고체
산도 계수 (pKa)
2.07 · 2.07±0.50(Predicted)
색상
Off-white to pink
안정성
흡습성
InChI
1S/C11H6ClN3O6/c12-7-5(14-8(16)10(18)19)1-4(3-13)2-6(7)15-9(17)11(20)21/h1-2H,(H,14,16)(H,15,17)(H,18,19)(H,20,21)
InChIKey
RVGLGHVJXCETIO-UHFFFAOYSA-N
SMILES
Clc1c(cc(cc1NC(=O)C(=O)O)C#N)NC(=O)C(=O)O

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

독성 정보

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

안전 데이터

wgk
WGK 3
스토리지 클래스
11 - Combustible Solids

화학 및 산업

약리 정보

ATC Code · 3건

S01GX05

S - Sensory organs

QS - Sensory organs

Pharmacodynamics · 1건

Lodoxamide is a mast cell stabilizer that inhibits the in vivo Type 1 immediate hypersensitivity reaction. Lodoxamide therapy inhibits the increases in cutaneous vascular permeability that are associated with reagin or IgE and antigen-mediated reactions.

Mechanism of Action · 1건

Although lodoxamide's precise mechanism of action is unknown, it is postulated that it prevents calcium influx into mast cells upon antigen stimulation and therefore stabilizes the membrane. By stabilizing the mast cell membrane from degranulation, lodoxamide consequently inhibits the release of intracellular histamine and other chemoattractant factors that primarily cause ocular symptoms. Lodoxamide's mechanism of action may be similar to cromolyn sodium, as both exhibit cross-tachyphylaxis.

Biological Half-LifeElimination half-life was 8.5 hours in urine.
FDA Pharmacological Classification · 5건

SPU695OD73

LODOXAMIDE

Physiologic Effects [PE] - Decreased Histamine Release

Established Pharmacologic Class [EPC] - Mast Cell Stabilizer

Lodoxamide is a Mast Cell Stabilizer. The physiologic effect of lodoxamide is by means of Decreased Histamine Release.

MeSH Pharmacological Classification · 1건

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)

Absorption, Distribution and Excretion · 2건

In a study of twelve healthy adult volunteers, topical administration of lodoxamide tromethamine ophthalmic solution 0.1%, one drop in each eye four times per day for ten days, did not result in any measurable lodoxamide plasma levels at a detection limit of 2.5 ng/mL.

관련 반응

0건
반응 기록 만들기
아직 관련 반응이 없습니다

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트

데이터베이스 식별자

CAS
53882-12-5
PubChem CID
44564
DTXSID
DTXSID9057767
ChEMBL
CHEMBL1201266
ChEBI
CHEBI:135333
UNII
SPU695OD73
Nikkaji
J10.842A

Urinary excretion is the major route of elimination.

응용 분야

용도Lodoxamide is an antiallergic drug that acts as a mast cell stabilizer. It is effective in the treatment of allergic conjunctivitis and in decreasing vascular permeability.

상·하류 제품 정보

상류 원료

4-클로로-3,5-디니트로벤조익산클로로글리옥실산에틸에스테르염화 제일석4-CHLORO-3,5-DINITROBENZONITRILE